Director's Messages

NINDS is excited to participate in Brain Awareness Week during March 11-17.

The National Advisory Neurological Disorders and Stroke (NANDS) Council met virtually from February 14-15, 2024. The NANDS Council is composed of highly accomplished scientists and clinicians as well as members of the public, such as representatives from patient groups. Together, these Council members bring broad expertise and experience to guide NINDS on program planning, policies, and research priorities. They also provide a second level of review for all grants and cooperative agreements that NINDS is considering for funding and review ongoing programs in both the extramural and intramural research programs.
As we head into the new year at NINDS, it’s time again to reflect on all that has come and gone in the past twelve months. Even as we face complex challenges in neuroscience research and the diseases and conditions we hope to improve, I am proud of the progress we and our many partners have achieved.
As the leaves change colors this fall and 2023 rapidly comes to an end, Washington, D.C. will once again host the world's largest convening of neuroscientists at the annual meeting of the Society for Neuroscience, taking place from November 11-15. Simply put, it is one of my favorite times of the year as we benefit from front row seats to the latest cutting-edge scientific advances, take time to catch up with old friends, and connect with new NINDS grantees — especially the up-and-coming generation of neuroscience trainees.
NINDS-funded science is the foundation that supports the development of new diagnostics and treatments for neurological disorders.
The nervous system is exceedingly complex and our lack of understanding of how it works stymies our efforts to develop treatments for neurological disorders. The brain, composed of 85 billion neurons and trillions of connections with an equal number of glial, vascular and immune cells, functions as an interrelated web to process information.
Each September, Pain Awareness month gives us an opportunity to reflect on the needs of the millions of people with chronic pain, as well as the research that we hope will better prevent and treat it.
Earlier this summer, NINDS hosted our annual Nonprofit Forum, an annual event in which nonprofit leaders can network with colleagues and engage in discussions with NINDS staff. This year, considerable attention was paid to the emerging field of gene-targeted treatments for multiple neurological conditions.
Today, I am happy to announce that the findings and recommendations from our two-year strategic planning effort for health disparities and equity research are published in a special issue of Neurology.
The annual NINDS Nonprofit Forum, taking place July 24-25, 2023, brings together organizations that represent the many neurological diseases within the NINDS portfolio. It’s a valuable venue for the organizations to collaborate and share lessons learned among themselves; and for NINDS to understand how we can most effectively work with organizations to address research needs and challenges.